Imatinib mesylate and the management of chronic myeloid leukemia (CML)

Koca, Ebru; Haznedaro�lu, �brahim C.

Imatinib mesylate and the management of chronic myeloid leukemia (CML) [Turk J Hematol]

Turk J Hematol. 2005; 22(4): 161-172

Imatinib mesylate and the management of chronic myeloid leukemia (CML)

Ebru Koca, �brahim C. Haznedaro�lu
Department Of Internal Medicine, Hematology Unit, Hacettepe University School Of Medicine, Ankara, Turkey

Keywords: Chronic myeloid leukemia (CML), Imatinib mesylate, BCR-ABL, Signal transduction inhibitor.

Ebru Koca, �brahim C. Haznedaro�lu. Imatinib mesylate and the management of chronic myeloid leukemia (CML). Turk J Hematol. 2005; 22(4): 161-172

Corresponding Author: �brahim C. Haznedaro�lu, T�rkiye

TOOLS

Full Text PDF

Download citation

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

Share with email

Send email to author

Similar articles

PubMed

Google Scholar

In authors and institutes

In titles and abstracts

In keywords

In all


	E-ISSN: 1308-5263
Archive Most Accessed Articles Most Cited Articles Aims and Scope Instructions For Authors Editorial Board Advisory Board Manuscript Submission Why to Submit Search Contact